Researchers from the Indian Institute of Technology (IIT) Guwahati, in collaboration with Bose Institute Kolkata, have unveiled a revolutionary injectable hydrogel designed to transform breast cancer treatment. This novel hydrogel-based system aims to significantly enhance drug delivery, providing precise, localized therapy while reducing the toxic
Lupin Limited announced on Thursday the launch of its generic cancer treatment drug in the US market. The Mumbai-based pharmaceutical firm has introduced Doxorubicin Hydrochloride Liposome Injection in single-dose vials. This launch follows the approval from the US Food and Drug Administration (FDA) received by Lupin’s
The $4.20-billion pharmaceutical market of the Philippines accounts for a significant market for Venus Remedies from the ASEAN region as the company moves a step closer towards emerging as the top oncology medicine supplier from India in Southeast Asia Venus Remedies’ oncology wing has
